Sheikh Kazim, Jiang Yanming, Bullock Claudia M
Centers for Medicare and Medicaid Services, U.S. Department of Health and Human Services, 601 East 12th Street, Kansas City, MO 64106, USA.
Ann Vasc Surg. 2007 Jul;21(4):496-504. doi: 10.1016/j.avsg.2007.03.029.
Many previous studies of vascular procedures have found sex and race differences in surgical mortality that were attributed to differential prevalence of comorbidity. Adjustment for selected comorbid conditions does not entirely remove bias. In addition to adjustments for other covariates, surgical mortality ratios in this study were adjusted for coexistent conditions that caused postoperative death but were unrelated to the procedure. The adjusted mortality was, therefore, attributable to the procedure. Medicare administrative and death certificate data on beneficiaries aged 65-99 years who resided in Indiana and Kentucky and who had 6,016 major vascular procedures in 1994-1997 were used. In Cox proportional hazard models, male-to-female and nonwhite-to-white surgical mortality ratios were adjusted for age, sex, or race; weighted Charlson comorbidity score; length of hospital stay; and fatal coexisting conditions (FCCs). Altogether, 3,333 patients died within 30 postoperative days. There were sex and/or race differences in mortality caused by aortic aneurysm, stroke, and diabetes (P < 0.05). Unadjusted, all-cause 30-day mortality was higher in women and nonwhite patients than in men and white patients following coronary artery bypass graft (CABG) procedure (P < 0.03). Mortality following all non-CABG procedures combined was lower in women than in men (P < 0.02). In multivariate analyses, 30-day mortality following CABG, adjusted for covariates, was lower in men than in women (hazard ratio [HR] = 0.88, 95% confidence interval [CI] 0.79-0.98), but there was no sex difference after adjustment for only FCC (HR = 0.94, 95% CI 0.85-1.05). Mortality following all non-CABG procedures combined was higher in men than in women, but this difference was insignificant after adjustment for comorbidity and/or FCC (HR = 1.05, 95% CI 0.93-1.17). Age- and sex-adjusted 30-day mortality following CABG was higher in nonwhite patients than in white patients (HR = 1.37, 95% CI 1.08-1.74), and this race difference persisted after further adjustments. There were no significant sex or race differences in surgical mortality following carotid endarterectomy, non-CABG thoracoabdominal procedures, or procedures in the limbs. Adjustments for covariates did not alter race difference in post-CABG surgical mortality. Adjustment for comorbid conditions slightly affected sex differences in mortality following CABG and all non-CABG procedures combined, but adjustment for FCC reduced these differences to insignificant levels.
此前许多关于血管手术的研究发现,手术死亡率存在性别和种族差异,这归因于合并症患病率的不同。对选定的合并症进行调整并不能完全消除偏差。除了对其他协变量进行调整外,本研究中的手术死亡率还针对导致术后死亡但与手术无关的并存疾病进行了调整。因此,调整后的死亡率归因于手术。使用了医疗保险管理数据和死亡证明数据,这些数据来自于1994年至1997年期间居住在印第安纳州和肯塔基州、年龄在65至99岁之间且接受了6016例主要血管手术的受益人。在Cox比例风险模型中,针对年龄、性别或种族;加权Charlson合并症评分;住院时间;以及致命并存疾病(FCCs),对男性与女性、非白人与白人的手术死亡率进行了调整。总共有3333名患者在术后30天内死亡。在由主动脉瘤、中风和糖尿病导致的死亡率方面存在性别和/或种族差异(P<0.05)。未经调整时,冠状动脉旁路移植术(CABG)后,女性和非白人患者的全因30天死亡率高于男性和白人患者(P<0.03)。所有非CABG手术合并后的死亡率女性低于男性(P<0.02)。在多变量分析中,针对协变量调整后,CABG术后30天死亡率男性低于女性(风险比[HR]=0.88,95%置信区间[CI]0.79 - 0.98),但仅针对FCC进行调整后不存在性别差异(HR = 0.94,95%CI 0.85 - 1.05)。所有非CABG手术合并后的死亡率男性高于女性,但在对合并症和/或FCC进行调整后,这种差异不显著(HR = 1.05,95%CI 0.93 - 1.17)。CABG术后经年龄和性别调整的30天死亡率非白人患者高于白人患者(HR = 1.37,95%CI 1.08 - 1.74),并且在进一步调整后这种种族差异仍然存在。在颈动脉内膜切除术、非CABG胸腹手术或肢体手术的手术死亡率方面不存在显著的性别或种族差异。对协变量的调整并未改变CABG术后手术死亡率的种族差异。对合并症的调整对CABG和所有非CABG手术合并后的死亡率性别差异有轻微影响,但对FCC进行调整后将这些差异降低到了不显著的水平。